Boston Scientific Corp
- Stock
- Ticker BSX
- ISIN US1011371077
- NYSE
Performance, volatility and drawdowns of Boston Scientific Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $19,562. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −61.5% in 10/2026, measured from the peak in 09/2025. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 4,561 | 4,663 | 5,061 | 5,065 | 5,286 | 5,203 | 5,442 | 5,138 |
| Gross profit | 3,095 | 3,210 | 3,424 | 3,542 | 3,679 | 3,614 | 3,848 | 3,428 |
| Operating income | 675 | 921 | 819 | 1,048 | 825 | 1,101 | 1,178 | 828 |
| EBITDA | 1,023 | 1,246 | 930 | 1,165 | 1,190 | 1,452 | 1,533 | 1,189 |
| Net income | 562 | 672 | 795 | 755 | 670 | 1,339 | 905 | 580 |
| Earnings per share | 0.38 | 0.45 | 0.53 | 0.51 | 0.45 | 0.90 | 0.61 | 0.40 |
| Balance sheet | ||||||||
| Total assets | 39,395 | 40,140 | 41,559 | 42,707 | 43,673 | 44,351 | 45,216 | 45,461 |
| Liabilities | 17,392 | 17,694 | 18,906 | 19,077 | 19,201 | 18,247 | 20,044 | 19,588 |
| Equity | 21,770 | 22,212 | 22,418 | 23,394 | 24,233 | 25,864 | 24,930 | 25,630 |
| Cash | 414 | 725 | 534 | 1,275 | 1,965 | 1,453 | 539 | 609 |
| Cash flow | ||||||||
| Operating cash flow | 1,456 | 541 | 1,286 | 1,343 | 1,364 | 348 | 1,474 | 1,048 |
| Capital expenditure | -277 | -187 | -157 | -181 | -351 | -177 | -195 | -180 |
| Free cash flow | 1,179 | 354 | 1,129 | 1,162 | 1,013 | 171 | 1,279 | 868 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +54.5%, weakest 2020 at −20.5%. 8 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 2 Nov 2026 | $0.40 |
| 3 Aug 2026 | $0.61 |
| 1 May 2026 | $0.90 |
| 17 Feb 2026 | $0.45 |
| 3 Nov 2025 | $0.51 |
| 1 Aug 2025 | $0.53 |
| 1 May 2025 | $0.45 |
| 18 Feb 2025 | $0.38 |
| 1 Nov 2024 | $0.32 |
| 1 Aug 2024 | $0.22 |
| 1 May 2024 | $0.33 |
| 20 Feb 2024 | $0.34 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €55bn
- Market cap in trading currency
- $60.8bn
- Enterprise value
- $61.3bn
- P/E
- 17.8
- P/S
- 2.89
- P/B
- 2.37
- EV/Sales
- 2.91
- EV/EBITDA
- 11.4
- Earnings yield
- 5.6%
- FCF yield
- 5.5%
Results (last four quarters)
- Revenue
- $21.1bn
- Gross profit
- $14.6bn
- EBITDA
- $5.36bn
- Net income
- $3.49bn
- Earnings per share
- $2.36
- Revenue per share
- $14.54
- Revenue growth
- +1.4%
- Earnings growth
- −23.2%
Profitability
- Gross margin
- 69.1%
- Operating margin
- 18.7%
- Net margin
- 16.6%
- Return on equity
- 14.3%
- Return on assets
- 7.7%
Balance sheet and cash flow
- Cash
- $609m
- Cash per share
- $0.42
- Financial debt
- $1.04bn
- Debt/equity %
- 4
- Current ratio
- 1.36
- Book value per share
- $17.68
- Operating cash flow
- $4.23bn
- Free cash flow
- $3.33bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 1.45bn
- Volume
- 14.6m
- Avg. volume 3 months
- 19.7m
- Relative volume
- 0.8
Price and technicals
- Price
- $41.98
- 1 day
- −2.3%
- 52-week high
- $101.58
- 52-week low
- $41.58
- Distance to 52-week high
- −58.7%
- Distance to 52-week low
- +1.0%
- Distance to 50-day line
- −4.2%
- Distance to 200-day line
- −20.9%
- RSI (14)
- 42
- Volatility 1M
- 43.9%
Performance
- 1 week
- −5.3%
- 1 month
- −8.8%
- 3 months
- −14.3%
- 6 months
- −27.3%
- YTD
- −56.0%
- 1 year
- −56.7%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has BSX performed since 11/2016?
$10,000 grew to $19,562 by 20 Nov 2026, which is +6.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is BSX?
Volatility was 23.3% per year, measured on monthly returns. The largest decline from a peak was −61.5%, with the low in 10/2026.
How does BSX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BSX returned +6.9% at 23.3%. The correlation of monthly returns was 0.45; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.